Raia Drogasil S.A.
RADLY
$3.62
-$0.07-1.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.24B | 7.81B | 7.29B | 7.02B | 6.97B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.24B | 7.81B | 7.29B | 7.02B | 6.97B |
| Cost of Revenue | 5.76B | 5.49B | 5.12B | 4.93B | 4.88B |
| Gross Profit | 2.48B | 2.32B | 2.17B | 2.10B | 2.09B |
| SG&A Expenses | 1.96B | 1.84B | 1.74B | 1.68B | 1.68B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 36.95M | -4.33M | -4.33M | -4.33M | -3.04M |
| Total Operating Expenses | 7.75B | 7.32B | 6.86B | 6.61B | 6.56B |
| Operating Income | 486.96M | 482.08M | 434.02M | 414.56M | 413.74M |
| Income Before Tax | 250.90M | 254.98M | 247.11M | 226.62M | 235.85M |
| Income Tax Expenses | 16.65M | 24.51M | 10.52M | 13.65M | 27.39M |
| Earnings from Continuing Operations | 234.25 | 230.47 | 236.59 | 212.97 | 208.46 |
| Earnings from Discontinued Operations | 2.23M | 3.89M | 3.89M | 3.89M | 3.89M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -331.10K | -521.10K | -3.16M | -2.49M | -1.30M |
| Net Income | 236.15M | 233.84M | 237.32M | 214.37M | 211.05M |
| EBIT | 486.96M | 482.08M | 434.02M | 414.56M | 413.74M |
| EBITDA | 646.49M | 634.30M | 567.74M | 546.18M | 542.75M |
| EPS Basic | 0.14 | 0.14 | 0.14 | 0.13 | 0.11 |
| Normalized Basic EPS | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 |
| EPS Diluted | 0.14 | 0.14 | 0.14 | 0.13 | 0.11 |
| Normalized Diluted EPS | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 |
| Average Basic Shares Outstanding | 6.56B | 6.59B | 6.72B | 6.72B | 7.97B |
| Average Diluted Shares Outstanding | 6.63B | 6.62B | 6.75B | 6.75B | 7.99B |
| Dividend Per Share | 0.06 | 0.07 | 0.04 | 0.05 | 0.03 |
| Payout Ratio | 50.08% | 50.54% | 39.94% | 44.30% | 40.81% |